Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Join

Subscribe or Register

Existing user? Login

Michael Dixon

Michael Dixon is lead pharmacist for R&D and medicines information.

Contact Info

Email:
michael.dixon1@nhs.net

Recent stories

  • How clozapine patients can be monitored safely and effectively

    2 JUN 2014Updated: 2 JUN 2014Comments (4)

    Patients who are taking clozapine require ongoing monitoring because of the risk of serious blood dyscrasias. What should pharmacists be checking before they dispense the medicine? The drug is subject to strict monitoring requirements because it is associated with serious side effects.

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.